<SEC-DOCUMENT>0001564590-18-022998-index.html : 20180912
<SEC-HEADER>0001564590-18-022998.hdr.sgml : 20180912
<ACCEPTANCE-DATETIME>20180912073024
ACCESSION NUMBER:		0001564590-18-022998
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180911
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
FILED AS OF DATE:		20180912
DATE AS OF CHANGE:		20180912

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Atara Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001604464
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				460920988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36548
		FILM NUMBER:		181065941

	BUSINESS ADDRESS:	
		STREET 1:		611 GATEWAY BLVD
		STREET 2:		SUITE 900
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-278-8930

	MAIL ADDRESS:	
		STREET 1:		611 GATEWAY BLVD
		STREET 2:		SUITE 900
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>atra-8k_20180911.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: atra-8k_20180911.htm

</DOCUMENT>
</SEC-DOCUMENT>